AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Discover user-friendly retirement planning software designed to simplify your financial planning and help you achieve your goals.
18,437 articlesAbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
FedEx Freight spins off to operate as an independent unit with about $9 billion in revenue, aiming to sharpen its foc...
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
The Technology Innovation Institute warns that AI agents operating in live systems require auditable proof of actions...
Alpha Omega Semiconductor stock has doubled this year, but is the rally justified? This guide breaks down the busines...
As power demand climbs, nuclear energy offers reliable baseload power and steady dividends. Here are three nuclear st...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Investors are buzzing about Micron Technology as AI and data-center demand shift the memory market. This article expl...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
A crypto treasury firm AVAX faced Nasdaq scrutiny but bounced back after a strategic reverse split. This article brea...